feed,title,long_url,short_url
InsiderMonkey,HSBC Downgrades Biogen Inc. (BIIB) to Reduce Despite Pipeline Progress,https://insidermonkey.com/blog/--1661772,
InsiderMonkey,Analysts Split on AbbVie Inc. (ABBV) as BofA Cuts Target and HSBC Turns Bullish,https://insidermonkey.com/blog/--1661743,
InsiderMonkey,UBS Reiterates Neutral on Novo Nordisk A/S (NVO) Despite Wegovy Dose Progress,https://insidermonkey.com/blog/--1661770,
InsiderMonkey,"Truist Sees Upside in Lantheus Holdings, Inc. (LNTH) Despite PYLARIFY Pressure",https://insidermonkey.com/blog/--1661780,
InsiderMonkey,"Merck & Co., Inc. (MRK) Sees Mixed Analyst Views as Europe Advances WINREVAIR Review",https://insidermonkey.com/blog/--1661785,
InsiderMonkey,BofA Raises Teva Pharmaceuticals Industries Limited (TEVA) Target to $32 as Barclays Initiates Overweight,https://insidermonkey.com/blog/--1661794,
InsiderMonkey,Sanofi (SNY) Shares Under Pressure After JPMorgan and Guggenheim Downgrades,https://insidermonkey.com/blog/--1661798,
InsiderMonkey,Guggenheim Sets $62 Target on Bristol-Myers Squibb Company (BMY) After FDA Priority Review,https://insidermonkey.com/blog/--1661800,
InsiderMonkey,Pfizer Inc (PFE) Rating Steady Amid Neutral Market Outlook and Pipeline Progress,https://insidermonkey.com/blog/--1661803,
